Area of research
Endocrinology, Diabetes and Metabolism · Pathology and Forensic Medicine
Research interest
Research interests include Medicine, Graves' disease, Internal medicine, Thyroid, Methylprednisolone, and Graves' ophthalmopathy.
Process to radioactive iodine treatment for Graves’ hyperthyroidism: condemned or absolved?
Thyroid Eye Disease: Epidemiology, Natural History, and Risk Factors
Psychological complications in patients with acromegaly: relationships with sex, arthropathy, and quality of life
The 2021 European Group on Graves’ orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves’ orbitopathy
Asymmetry indicates more severe and active disease in Graves’ orbitopathy: results from a prospective cross-sectional multicentre study
Antithyroid drugs in Graves’ hyperthyroidism: differences between “block and replace” and “titration” regimes in frequency of euthyroidism and Graves’ orbitopathy during treatment
2018 European Thyroid Association Guideline for the Management of Graves’ Hyperthyroidism
Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO): a randomised, observer-masked, multicentre trial
Predictive score for the development or progression of Graves’ orbitopathy in patients with newly diagnosed Graves’ hyperthyroidism
Graves’ orbitopathy as a rare disease in Europe: a European Group on Graves’ Orbitopathy (EUGOGO) position statement
Does early response to intravenous glucocorticoids predict the final outcome in patients with moderate-to-severe and active Graves’ orbitopathy?
Meeting abstracts from the 64th British Thyroid Association Annual Meeting
The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy
The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism
PREGO (presentation of Graves’ orbitopathy) study: changes in referral patterns to European Group On Graves’ Orbitopathy (EUGOGO) centres over the period from 2000 to 2012
A 2013 European survey of clinical practice patterns in the management of Graves' disease
Effects of Amiodarone, Thyroid Hormones and CYP2C9 and VKORC1 Polymorphisms on Warfarin Metabolism: A Review of the Literature
Efficacy and Safety of Three Different Cumulative Doses of Intravenous Methylprednisolone for Moderate to Severe and Active Graves' Orbitopathy
Amiodarone‐induced thyrotoxicosis, an overview of <scp>UK</scp> management